Medicines Formulary

Medicines A–Z

A

Drug name	NICE TAs	Comments
Alfuzosin M/R tablets
Alfuzosin tablets
Alglucosidase alfa injection		NHSE commissioned.
Alimemazine (Trimeprazine)		For children as per guideline
Alirocumab (Praluent®)	TA393 - Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia	To be used in line with NICE TA
Aliskiren tablets
Alitretinoin 30mg capsules	TA177 - Alitretinoin for the treatment of severe chronic hand eczema
Allopurinol tablets
Alogliptin (Vipidia®)		1st line choice
Alpelisib	TA816: Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.